AppYonder

Biostock

Tudor Avram

No ratings yetFinanceAges 4+

Get it free on the App StoreOpens Apple's App Store

Screenshots

About this app

Biostock makes biotech investing accessible. Whether you're new to the markets or a seasoned investor, understanding biotech stocks can be overwhelming. Clinical trials, FDA decisions, PDUFA dates, analyst ratings - there's a lot to track. Biostock brings it all together in one clean, easy-to-understand app. RESEARCH SMARTER Search any biotech stock and instantly see what matters: upcoming catalysts, FDA timelines, analyst sentiment, and recent news. No more digging through SEC filings or scattered sources. TRACK WHAT MATTERS Create watchlists to monitor your favorite stocks. See all upcoming catalysts across your portfolio at a glance so you never miss an important event. BUILT FOR CLARITY We translate complex biotech data into clear, actionable insights. Color-coded ratings help you quickly assess risk. Plain-language summaries explain what each catalyst means for the stock. KEY FEATURES - Pulse: AI-analyzed SEC filings with sentiment scoring - Catalyst calendar with FDA, clinical, and earnings events - Stock screener with biotech-specific filters - Signal Picks: daily trading strategy with backtested results - Analyst ratings and price targets - Custom watchlists with calendar view - Real-time stock prices and market data WHO IT'S FOR • New investors learning to research biotech stocks • Retail traders tracking catalyst-driven opportunities • Anyone who wants biotech data without the complexity Start making sense of biotech. Get Biostock today.

What's new

Version 3.0 · Oct 28, 2026

- New: raise risk, the chance a company announces a dilutive stock offering in the next 60 days, shown as a tier on stock pages - Raise risk sits inside Financial Health, with the company's raise history (last raise, price since, raises in 24 months, shelf on file) - Screener: hide high raise risk stocks, and see a raise risk badge on the stocks that have one - Cash runway now counts cash plus investments, not cash alone

More from Tudor Avram

You might also like